For pharmacists, from Drug Topics: Information for pharmacists about prescription medications and related subjects
February 9, 2012
By:From staff reports
Commercial electronic prescribing systems can significantly reduce medication errors in the hospital setting, according to a study published in PLoS Medicine in January
 |
February 9, 2012
By:From staff reports
An FDA advisory panel recommended against using denosumab (Xgeva, Amgen) to delay or prevent the spread of castration-resistant prostate cancer at risk for bone metastases. The FDA?s Oncologic Drugs Advisory Committee concluded that the drug offered a statistical benefit but not a clinical benefit.
|
February 9, 2012
By:From staff reports
The American Society of Health Systems Pharmacists published a new guide cardiovascular care meant to help pharmacists and other healthcare providers save lives in emergency settings
|
February 3, 2012
By:From staff reports
Hospitals and healthcare facilities should require all employees to get an annual flu shot, a group representing many of the nation?s largest employers emphasized again at a press conference Wednesday in Washington, D.C.
|
February 3, 2012
By:From staff reports
FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.
|
February 2, 2012
By:From staff reports
Dutasteride (Avodart, GlaxoSmithKline) delays the progression of prostate cancer in men with low-risk prostate cancer, according to a new study.
|
February 2, 2012
By:From staff reports
Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are 3 times more likely to have a fall resulting in injury compared with those who don?t use SSRIs, according a study published online January 18 in the British Journal of Clinical Pharmacology.
|
February 2, 2012
By:From staff reports
The Federal Trade Commission turned thumbs down on Omnicare?s attempted acquisition of competitor PharMerica. The agency filed suit in federal court to block the hostile takeover.
|
February 2, 2012
By:From staff reports
FDA declined approval of the diabetes drug dapagliflozin (Bristol-Myers Squibb and AstraZeneca), based on the recommendations of 1 of its advisory committees.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Do you agree that pharmacists should have the authority to prescribe medications? | | | Yes | | 72% | | | No | | 28% | |
| |  | | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
